How immune cells in the brain affect nerve cell activity in neurodegenerative diseases

Microglial regulation of neuronal activity in TDP-43 neurodegeneration

NIH-funded research University of Texas Hlth Sci Ctr Houston · NIH-11080601

This study is looking at how brain immune cells called microglia help manage nerve cell activity when there are problems related to a protein linked to neurodegenerative diseases, using a special mouse model to see how these cells behave and interact with nerve cells, which could help find new treatments for conditions like Alzheimer's or ALS.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Sci Ctr Houston NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-11080601 on NIH RePORTER

What this research studies

This research investigates the role of microglia, the immune cells in the brain, in regulating nerve cell activity during neurodegeneration associated with TDP-43 protein. Using a specialized mouse model that mimics neurodegenerative conditions, the researchers will observe how microglia respond to changes in neuronal activity and their potential protective roles. The study employs advanced imaging techniques to visualize microglial behavior and interactions with neurons over time, aiming to uncover mechanisms that could lead to new therapeutic strategies for neurodegenerative diseases.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with neurodegenerative diseases such as ALS, frontotemporal lobar dementia, or Alzheimer's disease.

Not a fit: Patients with neurodegenerative conditions not related to TDP-43 protein aggregation may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance the protective functions of microglia, potentially slowing down or reversing neurodegeneration.

How similar studies have performed: While the specific approach of this research is novel, previous studies have shown that targeting microglial activity can have beneficial effects in other neurodegenerative models.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.